CardioGenics Holdings Inc. | Balance Sheet

Fiscal year is November-October. All values USD Thousands.
2011
2012
2013
2014
2015
Cash & Short Term Investments
669.20
27.00
263.10
70.70
49.90
Total Accounts Receivable
231.70
125.70
63.70
2.90
2.40
Other Current Assets
51.50
51.40
49.30
-
-
Total Current Assets
952.40
204.20
376.00
73.50
52.30
Net Property, Plant & Equipment
82.30
67.80
53.50
42.70
35.20
Intangible Assets
130.70
110.00
118.40
108.10
102.90
Other Assets
-
-
-
45.60
41.60
Total Assets
1,165.50
382.00
548.00
269.90
231.90
ST Debt & Current Portion LT Debt
25.70
102.60
111.70
404.20
206.40
Accounts Payable
103.50
149.30
253.60
-
-
Income Tax Payable
180.00
200.00
220.00
321.50
487.50
Other Current Liabilities
313.20
436.90
576.50
699.40
1,101.10
Total Current Liabilities
622.40
888.80
1,161.80
1,425.00
1,794.90
Long-Term Debt
2.60
-
303.20
-
-
Total Liabilities
625.00
888.80
1,465.00
1,425.00
1,794.90
Common Equity (Total)
870.00
168.80
560.80
1,155.10
1,563.00
Total Shareholders' Equity
870.00
168.80
560.80
1,155.10
1,563.00
Total Equity
540.40
506.80
917.00
1,155.10
1,563.00
Liabilities & Shareholders' Equity
1,165.50
382.00
548.00
269.90
231.90
Accumulated Minority Interest
329.50
337.90
356.20
-
-

About CardioGenics Holdings

View Profile
Address
6295 Northam Drive
Mississauga Ontario L4V 1W8
Canada
Employees -
Website http://www.cardiogenics.com
Updated 07/08/2019
CardioGenics Holdings, Inc. is a biotechnology company, which is engaged in the business of development and commercialization of diagnostic test products to the In Vitro Diagnostics testing market. Its products include QL Care Analyzer, Immunoassay Tests and Paramagnetic Beads. The company was founded by Yahia A.